LoginSignup
Linseneintopf
@Linseneintopf
5Mon·

Cybin

1
4 Comments
jkb92@jkb92
5Mon
Take a look at $ATAI or $MNMD, where they are probably already a bit further along.
•
1
•
profile image
Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin
5Mon
@jkb92 $ATAI is my favorite candidate here.👍🏻
•
2
•
jkb92@jkb92
5Mon
@All-in-or-nothing ditto, we're finally heading north again :)
•
1
•
profile image
Erich K.@Erich_aus_der_Steiermark
3Mon
I am currently expanding my position in a targeted manner, as February 2026 is probably the most important month in the company's history. Here are the facts for the watchlist:

Rebranding & Nasdaq move: The change has been complete since January - Cybin is now called Helus Pharma (ticker: HELP). The move to the Nasdaq provides the necessary visibility with the major institutional investors.

CYB003 (Depression): All eyes are waiting for the final updates on the 12-month data. If the remission rates remain stable (most recently an impressive 71%), this is the "golden ticket" for Phase 3.

CYB004 (anxiety disorder): The important topline data from phase 2 are also expected in Q1. A second potential blockbuster in the pipeline.
•
1
•
Join the conversation
Sign upLogin